Peer Review History

Original SubmissionJuly 1, 2022
Decision Letter - Dina Schneidman, Editor

Dear Prof. Reuter,

Thank you very much for submitting your manuscript "Dissecting peripheral protein-membrane interfaces" for consideration at PLOS Computational Biology.

As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments. In the revised version please emphasize the novelty of the current results relative to current knowledge of PMPs.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Dina Schneidman

Software Editor

PLOS Computational Biology

***********************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: In this study, Tubiana et al build on their previous published work [Fuglebakk et al 2018], in the same journal. They characterise the basis of interfacial binding sites (IBS) for a range of peripheral membrane proteins (PMPs), using an impressive number of proteins for their analysis. In particular, the study is able to take advantage of the recent release of a large number of AlphaFold (AF) structures, so is very timely.

In general, the study is well conducted and rigorous, with some interesting insights. I recommend publishing with a few small changes:

Larger comments:

Firstly, I’m a little unclear on exactly how the IBS are determined. It’s stated that the structural database includes known IBS, but seeing as this is an integral part of the analysis here, it would be good if this were expanded. If, for instance, the structural IBS were predicted using bioinformatics, is there a risk that the analyses here are biased by previous assumptions? Similarly, how were the IBS for the AF models determined?

The analysis is done on completely rigid structures, solved in most cases I presume in a soluble state. I feel that this represents a possible limitation: if the IBS changes upon membrane binding (especially seeing as many sites contain loops) might this skew or change the data at all? For instance, could hydrophobic residues become more prominent upon binding? It would be good if this was addressed in the discussion.

Whilst the AF models are a really nice addition to the story, is there a risk that the relatively low accuracy of the AF side chains might skew an analysis of “protrusions”? Could this explain the difference between the AF and non-AF structures in terms of hydrophobic protrusions at the IBS (20 vs 39%)?

As an additional thought (not necessary for publication, but interesting) it is known that some domains bind to membrane with far higher affinities than others. Can this knowledge feed into the analysis here? i.e. do the proteins with no hydrophobic protrusions at the IBS fall into families which typically have lower binding affinities? Or do PMPs with more Arg have higher affinities, which is why many PMPs have fewer Arg (so they don’t bind too tightly?)

Smaller comments:

• The number of AF models used is reported to be 1423 in the intro, but 1194 in the abstract and discussion. Is this a discrepancy?

• The figures were a little blurry and the graph labels were often difficult to read. I recommend larger labels and higher resolution for the final submission

• The provided GitHub link doesn’t work (pepr2ds). I think I found it, but this should be changed in the manuscript.

• P5 line 108: “we extent this dataset” > “we extend this dataset”

Reviewer #2: The work is technically well done and provides important data and models on amino acids and regions of proteins and domains that interact with lipid membranes.

The main shortcoming of the work is the novelty and significance. The peripheral proteins and domains that bind lipid membranes have been studied in great detail both computationally and experimentally. The work presented herein is technically solid and important but doesn't make a significant advance in new information on lipid binding amino acids or composition of the interfacial binding surface amino acids. Hydrophobic and aromatic amino acids have been identified extensively in previous studies. This is good as the computational work and models confirm what has previously been measured/known but doesn't advance the field in significantly new ways.

Reviewer #3: This article presents the collection of a dataset of peripheral membrane proteins (PMPs) belonging to 9 superfamilies. For each PMP, the authors characterized the interfacial binding site (IBS) and split the dataset into two datasets: the amino acids in the IBS and the rest amino acids. The authors analyzed the amino acid distribution in these datasets and applied a mathematical model of hydrophobic protrusions that the authors present in “Fuglebakk et al. PLoS Comput Biol 2018”. New patterns were discovered in the IBS, such as the over-representation of glycine amino acids and the preference for lysine over arginine amino acids. I believe that this new PMP dataset will contribute to the creation of novel machine learning algorithms and PMP prediction tools. I would therefore recommend the publication of the manuscript. However, some major comments must be addressed to improve the quality of the manuscript:

1) The manuscript is about “Dissecting peripheral protein-membrane interfaces” but as it is also mentioned by the authors “the IBS for each domain is broadly defined and is likely to include more amino acids than the ones actually interacting with the lipids”. I understand that it is not possible to manually dissect ~2500 proteins but since other researchers might use this dataset for training machine learning algorithms or validating prediction models, more emphasis should be given to removing from the IBS the amino acids that do not contribute to the protein-membrane affinity.

2) Most of the analysis is performed on the mathematical model of hydrophobic protrusions that the authors present in “Fuglebakk et al. PLoS Comput Biol 2018” instead of performing analysis on the dataset itself. It is like the purpose of the manuscript has changed to test the model of hydrophobic protrusions in a new dataset. The only analysis performed in the dataset is the amino acid distribution in the IBS vs the nonIBS sets. More analysis between all or the solvent-exposed amino acids in the IBS vs the nonIBS would provide better insights into important properties of the IBS. For example, the secondary structure elements between the IBS and nonIBS, the amino acid conservation between the IBS and nonIBS in each superfamily, etc.

I have also some minor comments and suggestions to improve the clarity of the presentation:

1) Main text, Page 11, Lines 237-243: I cannot understand why the fact that “proteins without hydrophobic protrusions at their IBS tend to have less protrusions in their IBS in general” is significant. The authors should elaborate more on the scope of this analysis.

2) The fact that glycine amino acids are over-represented in the IBS is interesting. Indeed, one possible explanation is that glycine amino acids provide flexibility, which helps hydrophobic loops to insert the membrane. Do you think that the absence of a side chain in glycine amino acids drives nearby hydrophobic and aromatic amino acids to be more solvent-exposed and thus it is easier for them to anchor on the membrane? If yes, you could also discuss it in the manuscript.

3) In Table 1 the column “Number of structures in common” should be described in the caption.

4) I suggest adding colors to Figures 5B, 7A, and S4.

5) In my opinion, the main text contains a lot of figures and tables. I suggest moving Figure 7 and Table 3 to the SI.

6) Main text, Page 25, Line 567. I believe there is a typo here and instead of Fig. 1, it should be Fig. 9.

7) Reference 9 and reference 11 are the same.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Robin Corey

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Revision 1

Attachments
Attachment
Submitted filename: answer_reviewers.docx
Decision Letter - Dina Schneidman, Editor

Dear Prof. Reuter,

We are pleased to inform you that your manuscript 'Dissecting peripheral protein-membrane interfaces' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Dina Schneidman

Software Editor

PLOS Computational Biology

***********************************************************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have done an excellent job in responding to my suggested changes, and I feel they have now soundly addressed all the points raised by myself and the other referees. It is my opinion that the manuscript is ready for publication.

Reviewer #2: The authors have more clearly addressed some of my concerns on novelty and significance.

Reviewer #3: The authors answered all my comments and revised their manuscript accordingly. Thus, I believe that the manuscript is ready for publication.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Robin Corey

Reviewer #2: No

Reviewer #3: No

Formally Accepted
Acceptance Letter - Dina Schneidman, Editor

PCOMPBIOL-D-22-01007R1

Dissecting peripheral protein-membrane interfaces

Dear Dr Reuter,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofia Freund

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .